LumiraDx to Present at Raymond James Institutional Investors Conference

Rhea-AI Summary

LumiraDx Limited (Nasdaq: LMDX) announced that CFO Dorian LeBlanc will present at the Raymond James Institutional Investors Conference on March 7, 2023, at 4:35 PM ET. A webcast link is available for the presentation.

LumiraDx specializes in next-generation point-of-care diagnostics, providing rapid and accessible solutions tailored to various healthcare settings. The company offers over 30 assays for infectious diseases, cardiovascular issues, diabetes, and coagulation disorders. Founded in 2014 and based in the UK, its solutions are utilized globally by healthcare institutions and organizations to enhance screening, diagnosis, and wellness monitoring.

LONDON, March 03, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX) (the “Company”) today announced that Chief Financial Officer, Dorian LeBlanc, will be presenting at the Raymond James Institutional Investors Conference on Tuesday, March 7^th, 2023 at 4:35pm ET. Webcast link below.

https://wsw.com/webcast/rj127/lmdx/1610638

About LumiraDx

LumiraDx Limited (Nasdaq: LMDX) is a next-generation point of care diagnostics company that is transforming community-based healthcare. Its actively controlled microfluidic technology provides fast, high performance and accessible diagnostic solutions wherever the patient is for nearly any testing scenario, creating unique testing options at the point of need.

The Company offers a broad menu of lab comparable tests on a single portable Platform, with more than 30 assays on the market and in the pipeline, covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders. The Company also supports high-complexity laboratory testing in an accessible high-throughput format to leverage current molecular laboratory operations.

Founded in 2014 and based in the UK, LumiraDx's diagnostic testing solutions are being deployed globally by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to help screen, diagnose, and monitor wellness as well as disease. More information on LumiraDx is available at www.lumiradx.com.

FAQ

When will LumiraDx CFO Dorian LeBlanc present at the Raymond James Institutional Investors Conference?

Dorian LeBlanc will present on March 7, 2023, at 4:35 PM ET.

What is LumiraDx's focus in the diagnostics field?

LumiraDx focuses on next-generation point-of-care diagnostics, offering rapid and accessible testing solutions.

How many assays does LumiraDx offer?

LumiraDx has more than 30 assays available on its platform.

When was LumiraDx founded?

LumiraDx was founded in 2014.

What kind of diseases does LumiraDx's testing cover?

LumiraDx's testing covers infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders.